| Dr Thomas G Marshall, MD | |
|
744 S Webster Ave, Green Bay, WI 54301-3505 | |
| (920) 433-3500 | |
| Not Available |
| Full Name | Dr Thomas G Marshall |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 37 Years |
| Location | 744 S Webster Ave, Green Bay, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669456182 | NPI | - | NPPES |
| 43361300 | Medicaid | WI | |
| 050032232 | Other | RAIL ROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 33892-020 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bellin Memorial Hospital | Green bay, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bellin Anesthesia Associates Sc | 1254357684 | 31 |
News Archive
Intact hearing is a prerequisite for learning to speak. This is why children who are born deaf are fitted with so-called cochlear implants as early as possible. Cochlear implants consist of a speech processor and a transmitter coil worn behind the ear, together with the actual implant, an encapsulated microprocessor placed under the skin to directly stimulate the auditory nerve via an electrode with up to 22 contacts.
This research, published on Oct. 12 on the Nature review website, provides evidence of a major concept could pave the way for the future use of these stem cells to treat humans, through perspective gene therapies.
A recent large German study has shown that a new combination therapy for breast cancer treatment leads to a lowered risk of the disease coming back. A commentary on this landmark clinical trial has been published in the latest issue of the Journal of Clinical Oncology by the researchers Masey Ross and Charles Geyer Jr. from the VCU Massey Cancer Center. The commentary was titled, "Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer?"
Sucampo Pharmaceuticals, Inc. today reported its consolidated financial results for the quarter and six months ended June 30, 2010.
Hollow gold nanospheres equipped with a targeting peptide find melanoma cells, penetrate them deeply, and then cook the tumor when bathed with near-infrared light. When heated with lasers, the actively targeted hollow gold nanospheres did eight times more damage to melanoma tumors in mice than did the same nanospheres that gathered less directly in the tumors.
› Verified 7 days ago
| Entity Name | Bellin Anesthesia Associates Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558318410 PECOS PAC ID: 1254357684 Enrollment ID: O20051014000796 |
News Archive
Intact hearing is a prerequisite for learning to speak. This is why children who are born deaf are fitted with so-called cochlear implants as early as possible. Cochlear implants consist of a speech processor and a transmitter coil worn behind the ear, together with the actual implant, an encapsulated microprocessor placed under the skin to directly stimulate the auditory nerve via an electrode with up to 22 contacts.
This research, published on Oct. 12 on the Nature review website, provides evidence of a major concept could pave the way for the future use of these stem cells to treat humans, through perspective gene therapies.
A recent large German study has shown that a new combination therapy for breast cancer treatment leads to a lowered risk of the disease coming back. A commentary on this landmark clinical trial has been published in the latest issue of the Journal of Clinical Oncology by the researchers Masey Ross and Charles Geyer Jr. from the VCU Massey Cancer Center. The commentary was titled, "Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer?"
Sucampo Pharmaceuticals, Inc. today reported its consolidated financial results for the quarter and six months ended June 30, 2010.
Hollow gold nanospheres equipped with a targeting peptide find melanoma cells, penetrate them deeply, and then cook the tumor when bathed with near-infrared light. When heated with lasers, the actively targeted hollow gold nanospheres did eight times more damage to melanoma tumors in mice than did the same nanospheres that gathered less directly in the tumors.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas G Marshall, MD 225 S Executive Dr, Brookfield, WI 53005-4266 Ph: (262) 787-4026 | Dr Thomas G Marshall, MD 744 S Webster Ave, Green Bay, WI 54301-3505 Ph: (920) 433-3500 |
News Archive
Intact hearing is a prerequisite for learning to speak. This is why children who are born deaf are fitted with so-called cochlear implants as early as possible. Cochlear implants consist of a speech processor and a transmitter coil worn behind the ear, together with the actual implant, an encapsulated microprocessor placed under the skin to directly stimulate the auditory nerve via an electrode with up to 22 contacts.
This research, published on Oct. 12 on the Nature review website, provides evidence of a major concept could pave the way for the future use of these stem cells to treat humans, through perspective gene therapies.
A recent large German study has shown that a new combination therapy for breast cancer treatment leads to a lowered risk of the disease coming back. A commentary on this landmark clinical trial has been published in the latest issue of the Journal of Clinical Oncology by the researchers Masey Ross and Charles Geyer Jr. from the VCU Massey Cancer Center. The commentary was titled, "Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer?"
Sucampo Pharmaceuticals, Inc. today reported its consolidated financial results for the quarter and six months ended June 30, 2010.
Hollow gold nanospheres equipped with a targeting peptide find melanoma cells, penetrate them deeply, and then cook the tumor when bathed with near-infrared light. When heated with lasers, the actively targeted hollow gold nanospheres did eight times more damage to melanoma tumors in mice than did the same nanospheres that gathered less directly in the tumors.
› Verified 7 days ago
Dr. Brian C Johnson, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 835 S Van Buren St, Green Bay, WI 54301 Phone: 920-433-0111 | |
Stephen A Brada, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2845 Greenbrier Rd, Green Bay, WI 54311 Phone: 920-288-3388 Fax: 920-288-3370 | |
Linda M Neuser, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 744 S Webster Ave, Green Bay, WI 54301 Phone: 920-433-5582 | |
Dr. Joel M Johnson, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 835 S Van Buren St, Green Bay, WI 54301 Phone: 920-443-0111 | |
Dr. Marshall A Longnecker, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 744 S Webster Ave, Green Bay, WI 54301 Phone: 920-433-3500 | |
Dr. Hwe Jae Song, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 139 Garden Gate Ct, Green Bay, WI 54313 Phone: 920-883-9527 | |
Dr. John H. Danner Iii, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 744 S Webster Ave, Green Bay, WI 54301 Phone: 920-433-3500 |